Translating whole‐genome doubling into precision medicine in cancer
Whole‐genome doubling creates a WGD‐positive tumor state characterized by persistent chromosomal instability, karyotypic diversification, and cellular stress. These same biological pressures drive aggressive tumor evolution while exposing therapeutic vulnerabilities, providing a rationale for WGD‐informed precision medicine. Whole‐genome doubling (WGD)
Sejung Lee, Junghyeok Lim, Jinhyuk Bhin
wiley +1 more source
On the analysis of genetic association with long-read sequencing data. [PDF]
He G, Scherer SW, Strug LJ.
europepmc +1 more source
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley +1 more source
Genetic Association Study of <i>IL23R</i> and <i>IL12B</i> Polymorphisms with Psoriasis in a Romanian Population. [PDF]
Matei-Man AM +9 more
europepmc +1 more source
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu +3 more
wiley +1 more source
Genetic association of NEAT1 gene polymorphism with the progression of colorectal cancer. [PDF]
Shiu BH +6 more
europepmc +1 more source
GFPT1 as a cross-ancestry validated target for degenerative spinal disease: genetic association in a Chinese cohort and functional characterization in zebrafish. [PDF]
Yang B +8 more
europepmc +1 more source
A systematic exploration of gut microbiota-driven blood metabolites in sepsis: an integrated bioinformatics and genetic association study. [PDF]
Zhang Y +5 more
europepmc +1 more source
Advancing drug development for systemic sclerosis by prioritizing findings from human genetic association studies. [PDF]
Hughes M +4 more
europepmc +1 more source

